ArticleNeuropsychiatric disease and treatment2016

Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study.

Hongyan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.